ES2032377T3 - Procedimiento para la preparacion de nuevos compuestos de piridina sustituidos con radicales basicos. (reserva del art. 167.2 cpe). - Google Patents
Procedimiento para la preparacion de nuevos compuestos de piridina sustituidos con radicales basicos. (reserva del art. 167.2 cpe).Info
- Publication number
- ES2032377T3 ES2032377T3 ES198686115896T ES86115896T ES2032377T3 ES 2032377 T3 ES2032377 T3 ES 2032377T3 ES 198686115896 T ES198686115896 T ES 198686115896T ES 86115896 T ES86115896 T ES 86115896T ES 2032377 T3 ES2032377 T3 ES 2032377T3
- Authority
- ES
- Spain
- Prior art keywords
- carbons
- preparation
- cpe
- reservation
- procedure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 2
- -1 AMINO Chemical class 0.000 abstract 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical group [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Inorganic Insulating Materials (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
COMPUESTOS PIRIDINICOS DE LA FORMULA I EN LA QUE R1 Y R2, INDEPENDIENTEMENTE UNO DEL OTRO, SIGNIFICAN HIDROGENO O ALQUILO DE 1 A 4 CARBONOS, F3 SIGNIFICA HIDROGENO O ALQUILO DE 1 O 2 CARBONOS, A SIGNIFICA ALQUILENO DE CADENA LINEAL O RAMIFICADA, DE 2 A 4 CARBONOS, N TIENE EL VALOR 0 O 1, Z REPRESENTA UN GRUPO DE LAS FORMULAS (II) ZA, ZB O ZC EN LAS QUE R4 ES HIDROGENO Y R5 ES FENILO O CINAMILO, O R4, R5, R7 Y R8, INDEPENDIENTEMENTE UNO DE OTRO, REPRESENTAN CADA UNO DE ELLOS PIRIDILO O FENILO, LLEVANDO EL FENILO, EVENTUALMENTE, UNO O DOS SUSTITUYENTES IGUALES O DIFERENTES DEL GRUPO DE LOS HALOGENOS Y DE LOS ALCOXI DE 1 O 2 CARBONOS, R6 ES HIDROGENOS O HIDROXI Y X SIGNIFICA LOS GRUPOS CIANO, AMINO O NITRO O EL RESTO -CO-R9, EN EL QUE R9 ES HIDROXI O ALCOXI DE 1 A 4 CARBONOS, Y LAS SALES FISIOLOGICAMENTE COMPATIBLES DE ESTOS COMPUESTOS Y SU EMPLEO EN MEDICAMENTOS, ASI COMO UN METODO PARA LA PREPARACION DE TALES COMPUESTOS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19853541428 DE3541428A1 (de) | 1985-11-23 | 1985-11-23 | Neue basisch substituierte pyridinverbindungen, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2032377T3 true ES2032377T3 (es) | 1993-02-16 |
Family
ID=6286631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES198686115896T Expired - Lifetime ES2032377T3 (es) | 1985-11-23 | 1986-11-15 | Procedimiento para la preparacion de nuevos compuestos de piridina sustituidos con radicales basicos. (reserva del art. 167.2 cpe). |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4792554A (es) |
| EP (1) | EP0224159B1 (es) |
| JP (1) | JPS62129271A (es) |
| CN (1) | CN86107899A (es) |
| AT (1) | ATE59637T1 (es) |
| AU (1) | AU587086B2 (es) |
| CA (1) | CA1256873A (es) |
| DE (2) | DE3541428A1 (es) |
| DK (1) | DK558786A (es) |
| ES (1) | ES2032377T3 (es) |
| FI (1) | FI864737A7 (es) |
| GR (1) | GR3001470T3 (es) |
| HU (1) | HU196998B (es) |
| IL (1) | IL80715A (es) |
| NO (1) | NO166321C (es) |
| NZ (1) | NZ218359A (es) |
| PH (1) | PH24129A (es) |
| PT (1) | PT83786B (es) |
| ZA (1) | ZA868834B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK623586A (da) * | 1985-12-27 | 1987-06-28 | Eisai Co Ltd | Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne |
| US4916142A (en) * | 1987-02-02 | 1990-04-10 | Boc, Inc. | N-heterocyclic-N-(4-piperidinyl)amides and pharmaceutical compositions and their use as analgesics |
| US6676967B1 (en) | 1993-09-20 | 2004-01-13 | Kos Pharmaceuticals, Inc. | Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia |
| US6080428A (en) | 1993-09-20 | 2000-06-27 | Bova; David J. | Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
| US6129930A (en) | 1993-09-20 | 2000-10-10 | Bova; David J. | Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night |
| US6746691B2 (en) | 1993-09-20 | 2004-06-08 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics |
| US6818229B1 (en) | 1993-09-20 | 2004-11-16 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE786565A (fr) * | 1971-07-23 | 1973-01-22 | Upjohn Co | Nouveaux oxydes de pyridine substitues et leur preparation |
| DE2334401A1 (de) * | 1973-07-06 | 1975-01-23 | Hoechst Ag | 2-nitro-3-aminoalkylamino-pyridine und verfahren zu ihrer herstellung |
| DE2900504A1 (de) * | 1979-01-08 | 1980-07-24 | Hoechst Ag | Neue substituierte 4-aminopyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| GB8320699D0 (en) * | 1983-08-01 | 1983-09-01 | Wellcome Found | Ethylenediamines |
-
1985
- 1985-11-23 DE DE19853541428 patent/DE3541428A1/de not_active Withdrawn
-
1986
- 1986-11-15 AT AT86115896T patent/ATE59637T1/de not_active IP Right Cessation
- 1986-11-15 ES ES198686115896T patent/ES2032377T3/es not_active Expired - Lifetime
- 1986-11-15 DE DE8686115896T patent/DE3676459D1/de not_active Expired - Fee Related
- 1986-11-15 EP EP86115896A patent/EP0224159B1/de not_active Expired - Lifetime
- 1986-11-20 FI FI864737A patent/FI864737A7/fi not_active Application Discontinuation
- 1986-11-21 DK DK558786A patent/DK558786A/da not_active Application Discontinuation
- 1986-11-21 NZ NZ218359A patent/NZ218359A/xx unknown
- 1986-11-21 PT PT83786A patent/PT83786B/pt not_active IP Right Cessation
- 1986-11-21 JP JP61276897A patent/JPS62129271A/ja active Pending
- 1986-11-21 NO NO864665A patent/NO166321C/no unknown
- 1986-11-21 US US06/933,532 patent/US4792554A/en not_active Expired - Fee Related
- 1986-11-21 HU HU864831A patent/HU196998B/hu not_active IP Right Cessation
- 1986-11-21 PH PH34509A patent/PH24129A/en unknown
- 1986-11-21 ZA ZA868834A patent/ZA868834B/xx unknown
- 1986-11-21 IL IL80715A patent/IL80715A/xx unknown
- 1986-11-21 AU AU65570/86A patent/AU587086B2/en not_active Ceased
- 1986-11-22 CN CN198686107899A patent/CN86107899A/zh active Pending
- 1986-11-24 CA CA000523703A patent/CA1256873A/en not_active Expired
-
1991
- 1991-02-12 GR GR91400031T patent/GR3001470T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62129271A (ja) | 1987-06-11 |
| HUT42473A (en) | 1987-07-28 |
| AU6557086A (en) | 1987-05-28 |
| CA1256873A (en) | 1989-07-04 |
| EP0224159A1 (de) | 1987-06-03 |
| ATE59637T1 (de) | 1991-01-15 |
| IL80715A (en) | 1990-08-31 |
| FI864737A7 (fi) | 1987-05-24 |
| NO166321C (no) | 1991-07-03 |
| AU587086B2 (en) | 1989-08-03 |
| US4792554A (en) | 1988-12-20 |
| HU196998B (en) | 1989-02-28 |
| GR3001470T3 (en) | 1992-10-08 |
| DK558786D0 (da) | 1986-11-21 |
| ZA868834B (en) | 1987-07-29 |
| NO864665L (no) | 1987-05-25 |
| CN86107899A (zh) | 1987-07-29 |
| PT83786B (pt) | 1989-06-30 |
| NZ218359A (en) | 1989-05-29 |
| DE3541428A1 (de) | 1987-05-27 |
| NO864665D0 (no) | 1986-11-21 |
| EP0224159B1 (de) | 1991-01-02 |
| FI864737A0 (fi) | 1986-11-20 |
| PT83786A (de) | 1986-12-01 |
| DE3676459D1 (de) | 1991-02-07 |
| DK558786A (da) | 1987-05-24 |
| NO166321B (no) | 1991-03-25 |
| PH24129A (en) | 1990-03-05 |
| IL80715A0 (en) | 1987-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2011210T3 (es) | Derivados de gem-difosfonato substituido, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| ES2021027B3 (es) | Compuestos sustituidos de piridinosulfonamida, composicion herbicida que los contiene, y metodo de preparacion de estos compuestos. | |
| ES2031841T3 (es) | Un procedimiento para la preparacion de derivados de 1,1-dioxido de 2-aminoalquil-1,2-benzoisotiazol-3-(2h)ona. | |
| ES2127919T3 (es) | 4-amino-piridinas, procedimiento para su preparacion, asi como medicamentos que contienen estos compuestos. | |
| ES2100907T3 (es) | Bencimidazoles, medicamentos que contienen estos compuestos y proced imiento para su preparacion. | |
| ES2058292T3 (es) | Derivados de indol. | |
| ES2054860T3 (es) | Nuevos derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion, asi como a su utilizacion como medicamentos. | |
| ES8105694A1 (es) | Procedimiento para la produccion de propenilaminas | |
| ES2040234T3 (es) | Derivados del tetrahidronaftaleno y medicamentos que los contienen. | |
| ES2221440T3 (es) | Derivados de acido aminofenoxiacetico como neuroprotectores. | |
| ES2063153T3 (es) | Amino-4 quinoleinas y naftiridinas, su procedimiento de preparacion y su aplicacion como medicamentos. | |
| ES8609303A1 (es) | Un procedimiento para la preparacion de un derivado de acido6-fluor-1,4-dihidro-4-oxo-7-piperazinilquinolin sustituido-3-carboxilico | |
| AR009938A1 (es) | Nuevos derivados de arilglicinamida, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos | |
| ES485274A1 (es) | Un procedimiento para la preparacion de derivados de fenil- piperacina | |
| MX7012A (es) | Procedimiento para preparar derivados de acido-cis,endo-2-azabiciclo-(5.3.0.)-decan-3-carboxilico. | |
| ES2004985A6 (es) | Procedimiento de preparacion de 1-4aminofenil-4-metil-7,8-metilendioxi-3,4-dihidro-5h-2,3-benzodiazepina y sus sales de adicion acidas | |
| ES2028865T3 (es) | Procedimiento mejorado para la preparacion de derivados de macrolidas. | |
| CO4900055A1 (es) | 3,4-di-indolil pirroles | |
| AR007969A1 (es) | Compuestos derivados de pirroles sustituidos, su utilizacion y composiciones farmaceuticas que contienen tales compuestos | |
| ES2026669T3 (es) | Procedimiento para la preparacion y el uso terapeutico de los beta-d-fenil tioxilosidos. | |
| ES2032377T3 (es) | Procedimiento para la preparacion de nuevos compuestos de piridina sustituidos con radicales basicos. (reserva del art. 167.2 cpe). | |
| MX9304424A (es) | Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion. | |
| ES8700246A1 (es) | Procedimiento para la fabricacion de nuevos derivados de la cumarina | |
| ES2032752T3 (es) | Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina. | |
| ES2133686T3 (es) | Nuevos derivados de benzopirano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 224159 Country of ref document: ES |